Anti-SARS-CoV-2 Neutralizing Responses in Various Populations: Use of a Rapid Surrogate Lateral Flow Assay and Correlations with Anti-RBD Antibody Levels.
Joël GozlanAudrey BaronAnders BoydMaud SalmonaDjeneba FofanaMarine MinierAudrey GabassiLaurence Morand-JoubertConstance DelaugerreSarah MaylinPublished in: Life (Basel, Switzerland) (2024)
The ichroma™ COVID-19 nAb test displayed high specificity and emerged as a valuable tool for monitoring anti-SARS-CoV-2 immunity. These findings contribute to understand the antibody response dynamics and underscore the potential of rapid tests in predicting protection against SARS-CoV-2 infection.